One-carbon metabolism: linking nutritional biochemistry to epigenetic programming of long-term development
CE Clare, AH Brassington, WY Kwong… - Annual review of …, 2019 - annualreviews.org
One-carbon (1C) metabolism comprises a series of interlinking metabolic pathways that
include the methionine and folate cycles that are central to cellular function, providing 1C …
include the methionine and folate cycles that are central to cellular function, providing 1C …
[HTML][HTML] Factor v Leiden thrombophilia
JL Kujovich - Genetics in medicine, 2011 - Elsevier
Factor V Leiden is a genetic disorder characterized by a poor anticoagulant response to
activated Protein C and an increased risk for venous thromboembolism. Deep venous …
activated Protein C and an increased risk for venous thromboembolism. Deep venous …
VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence …
Background The use of anticoagulant therapy during pregnancy is challenging because of
the potential for both fetal and maternal complications. This guideline focuses on the …
the potential for both fetal and maternal complications. This guideline focuses on the …
Thrombophilia in pregnancy: a systematic review
Growing evidence suggests that thrombophilia is associated with venous thromboembolism
(VTE) and adverse pregnancy outcomes. However, methodological limitations have made it …
(VTE) and adverse pregnancy outcomes. However, methodological limitations have made it …
Thrombophilic disorders and fetal loss: a meta-analysis
Background Our aim was to assess the strength of the controversial association between
thrombophilia and fetal loss, and to examine whether it varies according to the timing or …
thrombophilia and fetal loss, and to examine whether it varies according to the timing or …
Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians evidence-based clinical practice guidelines
This article discusses the management of venous thromboembolism (VTE) and
thrombophilia, as well as the use of antithrombotic agents, during pregnancy and is part of …
thrombophilia, as well as the use of antithrombotic agents, during pregnancy and is part of …
Recurrent miscarriage
DW Branch, C Heuser - … and Infertility: Integrating Modern Clinical and …, 2010 - Springer
Recurrent miscarriage is a common pathology fond in 1% to 5% of reproductively active
couples. This chapter discusses the possible causes of recurrent miscarriage, and …
couples. This chapter discusses the possible causes of recurrent miscarriage, and …
Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
This chapter about the use of antithrombotic agents during pregnancy is part of the Seventh
ACCP Conference on Antithrombotic and Thrombolytic Therapy: Evidence Based …
ACCP Conference on Antithrombotic and Thrombolytic Therapy: Evidence Based …
How strong is the association between maternal thrombophilia and adverse pregnancy outcome?: A systematic review
Z Alfirevic, D Roberts, V Martlew - … Journal of Obstetrics & Gynecology and …, 2002 - Elsevier
Objective: To determine whether inherited and acquired thrombophilias are associated with
adverse obstetric complications. Study Design: A systematic review; studies where women …
adverse obstetric complications. Study Design: A systematic review; studies where women …
Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder
JC Gris, E Mercier, I Quéré, G Lavigne-Lissalde… - Blood, 2004 - ashpublications.org
The prospective evaluation of the effect of thromboprophylaxis in women with one
unexplained pregnancy loss from the 10th week of amenorrhea was performed. A total of …
unexplained pregnancy loss from the 10th week of amenorrhea was performed. A total of …